| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.3 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |